FDA.reportPublic FDA data

NDC 85509-1001-01 - Cyclobenzaprine HCL

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
85509-1001
Requested NDC
85509-1001-01
Package NDCs from labels
85509-1001-9, 85509-1001-6, 85509-1001-3, 85509-1001-1, 85509-1001-01
Manufacturer
PHOENIX RX LLC
Effective date
2026-01-16
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
Cyclobenzaprine HCL - PHOENIX RX LLCPHOENIX RX LLC2026-01-16HUMAN PRESCRIPTION DRUG LABEL

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
85509-1001-1Cyclobenzaprine HCL120 in 1 BOTTLETABLET, FILM COATED1202
85509-1001-3Cyclobenzaprine HCL30 in 1 BOTTLETABLET, FILM COATED302
85509-1001-6Cyclobenzaprine HCL60 in 1 BOTTLETABLET, FILM COATED602
85509-1001-9Cyclobenzaprine HCL90 in 1 BOTTLETABLET, FILM COATED902

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
85509-1001-1EA - Each85509-100128522ea1-ab13-471d-8dbc-728cefe3de1412025-09-12
85509-1001-3EA - Each85509-1001bb8bece2-242a-4473-816b-c5dcd4acbe2212025-09-12
85509-1001-6EA - Each85509-100112fefb56-7807-47b3-be63-4b7cb0931ed312025-09-12
85509-1001-9EA - Each85509-100144e90feb-0a42-423d-89ca-676e3078da5612025-09-12

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 3 of 10 · 182 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
CYCLOBENZAPRINE HYDROCHLORIDECYCLOBENZAPRINE HYDROCHLORIDEPreferred Pharmaceuticals Inc.e343fd12-1ca2-418a-b690-f3e8f567596d2026-04-01Warnings, Adverse reactionsExact identifier
unii: 0VE05JYS2P
Cyclobenzaprine HydrochlorideCYCLOBENZAPRINE HYDROCHLORIDEPreferred Pharmaceuticals Inc.29ca9548-23b0-4c50-82cb-4f0564d7e0652026-04-01Warnings, Adverse reactionsExact identifier
unii: 0VE05JYS2P
Cyclobenzaprine HydrochlorideCYCLOBENZAPRINE HYDROCHLORIDEPreferred Pharmaceuticals, Inc.a4cc7965-2ba8-42e8-8c5c-b90145a6598a2026-04-01Warnings, Adverse reactionsExact identifier
application number: ANDA078722
rxcui: 828299
unii: 0VE05JYS2P
Cyclobenzaprine HydrochlorideCYCLOBENZAPRINE HYDROCHLORIDEREMEDYREPACK INC.fada6577-bcb8-422c-be37-08562919ebc92026-03-30Warnings, Adverse reactionsExact identifier
unii: 0VE05JYS2P
Cyclobenzaprine HydrochlorideCYCLOBENZAPRINE HYDROCHLORIDEPreferred Pharmaceuticals Inc.96b650d8-4ad5-42af-aa8c-aa0ac25abfb52026-03-17Warnings, Adverse reactionsExact identifier
unii: 0VE05JYS2P
CYCLOBENZAPRINE HYDROCHLORIDECYCLOBENZAPRINE HYDROCHLORIDEDirectRxcdc5b438-6b6b-0cdd-e053-2a95a90a7f752026-03-06Warnings, Adverse reactionsExact identifier
unii: 0VE05JYS2P
Cyclobenzaprine HydrochlorideCYCLOBENZAPRINE HYDROCHLORIDEDirect_Rx15aad4af-5c05-be36-e063-6294a90a9bb32026-03-05Warnings, Adverse reactionsExact identifier
unii: 0VE05JYS2P
Cyclobenzaprine HydrochlorideCYCLOBENZAPRINE HYDROCHLORIDENuCare Pharmaceuticals, Inc.4c3a3b4f-7b2b-3fe9-e063-6394a90aae472026-03-04Warnings, Adverse reactionsExact identifier
unii: 0VE05JYS2P
CYCLOBENZAPRINE HYDROCHLORIDECYCLOBENZAPRINE HYDROCHLORIDEBryant Ranch Prepackdc3cc6b6-c692-4986-8ff7-3a6cd8c85cb22026-03-04Warnings, Adverse reactionsExact identifier
unii: 0VE05JYS2P
CYCLOBENZAPRINE HYDROCHLORIDECYCLOBENZAPRINE HYDROCHLORIDEAsclemed USA, Inc.06da53af-5b46-4e32-a64c-9677e27ae2292026-02-14Warnings, Adverse reactionsExact identifier
unii: 0VE05JYS2P
CYCLOBENZAPRINE HYDROCHLORIDECYCLOBENZAPRINE HYDROCHLORIDESportpharm LLCd4e0f532-887b-40bb-80d6-5c4e5b1d64bf2026-02-11Warnings, Adverse reactionsExact identifier
unii: 0VE05JYS2P
CYCLOBENZAPRINE HYDROCHLORIDECYCLOBENZAPRINE HYDROCHLORIDEPD-Rx Pharmaceuticals, Inc.4eaa675a-c24c-4043-8fdf-9d59e5e4f4d52026-01-22Warnings, Adverse reactionsExact identifier
unii: 0VE05JYS2P
Cyclobenzaprine HydrochlorideCYCLOBENZAPRINE HYDROCHLORIDEPHOENIX RX LLC48c33e51-db07-af68-e063-6294a90a897e2026-01-19Warnings, Adverse reactionsExact identifier
unii: 0VE05JYS2P
CYCLOBENZAPRINE HYDROCHLORIDECYCLOBENZAPRINE HYDROCHLORIDEMedcore LLC1b834bd5-9ee6-42a4-819c-5c605fd18e1f2026-01-16Warnings, Adverse reactionsExact identifier
unii: 0VE05JYS2P
Cyclobenzaprine HCLCYCLOBENZAPRINE HCLPHOENIX RX LLC3a397e88-d267-feed-e063-6294a90a77102026-01-16Warnings, Adverse reactionsExact identifier
application number: ANDA078722
ndc (package): 85509-1001-9
ndc (package): 85509-1001-3
ndc (package): 85509-1001-6
ndc (package): 85509-1001-1
ndc (product): 85509-1001
ndc11 (package): 85509100101
rxcui: 828299
spl id: 488202dc-28f3-ad46-e063-6294a90a4238
spl set id: 3a397e88-d267-feed-e063-6294a90a7710
unii: 0VE05JYS2P
CYCLOBENZAPRINE HYDROCHLORIDECYCLOBENZAPRINE HYDROCHLORIDEAdvagen Pharma Limitedb2169957-9083-412c-a175-3071860c2b432026-01-13Warnings, Adverse reactionsExact identifier
rxcui: 828299
unii: 0VE05JYS2P
Cyclobenzaprine HydrochlorideCYCLOBENZAPRINE HYDROCHLORIDECoupler LLC47d22c6d-49fb-f97c-e063-6294a90a6ba12026-01-07Warnings, Adverse reactionsExact identifier
application number: ANDA077563
unii: 0VE05JYS2P
Cyclobenzaprine HydrochlorideCYCLOBENZAPRINE HYDROCHLORIDENORTHSTAR RX LLC2a3a13c3-116c-4e9e-a7f3-7ad7c80486c32026-01-02Warnings, Adverse reactionsExact identifier
rxcui: 828299
unii: 0VE05JYS2P
CYCLOBENZAPRINE HYDROCHLORIDECYCLOBENZAPRINE HYDROCHLORIDENorthwind Health Company, LLCc29cf8bd-2f63-ed4b-e053-2995a90ab6eb2026-01-01Warnings, Adverse reactionsExact identifier
unii: 0VE05JYS2P
CYCLOBENZAPRINE HYDROCHLORIDECYCLOBENZAPRINE HYDROCHLORIDENorthwind Health Company, LLCdae3be94-a40c-5be1-e053-2a95a90a14842026-01-01Warnings, Adverse reactionsExact identifier
unii: 0VE05JYS2P

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.